We Built a Sick-Care System. It's Time to Build a Healthcare System

U.S. healthcare spending reached $5.3 trillion in 2024, or $15,474 per person, while the country ranked last overall and in health outcomes among 10 high-income countries in the Commonwealth Fund’s comparison. SCU’s Russell H. Greenfield is urging payment-model, clinician-education, research, and outcome-measure changes to expand prevention-focused, person-centered care.

Analysis

This is an advocacy signal, not a reimbursement or regulatory change; the immediate earnings impact is negligible. The investable question is whether prevention gets paid for in a way that lets the party funding it capture the savings. Member turnover and fragmented care can leave insurers or providers paying for nutrition, behavioral-health, or care-coordination support while another organization benefits later. That makes durable patient attribution and risk-sharing—not broad “whole health” branding—the key competitive advantages.

Over 1–3 months, watch for concrete CMS or commercial-payer contract changes, not further calls for reform. Over 6–18 months, credible evidence of lower risk-adjusted total cost of care, improved outcomes, and repeatable implementation could favor integrated primary-care and care-management models. Conversely, broader screening and support can initially raise utilization and operating costs; providers exposed to fee-for-service revenue could face pressure if payment shifts before savings materialize. The press release provides no evidence that these economics have changed or that any specific approach has proven cost-effective.

Key Decisions for Investors

• No event-driven trade: the article does not announce a policy, contract, or reimbursement change.
• Watch CMS accountable-care and Medicare Advantage payment rules, plus payer contract disclosures, for durable attribution and explicit funding of prevention; these are nearer-term catalysts than education initiatives.
• Favor, selectively, healthcare operators that disclose sustained risk-adjusted cost savings and outcome gains under risk-bearing contracts; treat wellness or care-coordination claims without independently verifiable results as unproven.
• Falsify the structural thesis if prevention programs fail to improve total-cost or quality metrics, or if payment changes lag while care-delivery costs rise. Reassess only when comparable outcome, cost, and patient-retention data are available.